+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contract Research Organization Services Market by Type, Trial Phase, Therapeutic Area, Molecule Type, End-User - Global Forecast 2025-2030- Product Image
Contract Research Organization Services Market by Type, Trial Phase, Therapeutic Area, Molecule Type, End-User - Global Forecast 2025-2030- Product Image
Sale

Contract Research Organization Services Market by Type, Trial Phase, Therapeutic Area, Molecule Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674773
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Contract Research Organization Services Market grew from USD 87.00 billion in 2023 to USD 96.31 billion in 2024. It is expected to continue growing at a CAGR of 10.97%, reaching USD 180.36 billion by 2030.

Contract Research Organization (CRO) services encompass a spectrum of support activities provided to pharmaceutical, biotechnology, and medical device industries. These services span across drug discovery, clinical trials management, regulatory support, pharmacovigilance, and post-marketing surveillance. The necessity of CRO services arises from the need to streamline R&D processes, reduce costs, mitigate risks, and promote efficiency by outsourcing complex, resource-intensive activities to specialized external partners. The application of CRO services is vast, supporting areas from early-stage research and clinical trial conduct to regulatory submissions and beyond. This versatility allows end-users like pharma companies, medical device manufacturers, and academic institutions to focus on their core competencies while accessing advanced technological insights and regulatory navigation expertise.

The market for CRO services is primarily driven by the ever-increasing demand for innovative therapeutics, growing R&D expenditures, and the proliferation of biotech companies requiring specialized expertise. Additionally, globalization of clinical trials and regulatory requirements pressure companies to ensure compliance and efficiency, further accelerating CRO demand. Emerging opportunities are evident in the integration of AI and big data to enhance trial design and patient recruitment, offering significant ease in cost and time reduction. However, challenges such as high competitive rivalry, stringent regulatory frameworks, and the complexity of managing diverse geographical clinical trial needs pose limitations to market expansion.

Potential growth areas include the pursuit of AI-driven analytics, personalized medicine, and advancements in biotechnologies. A focus on enhancing data security and compliance within digital platforms will be crucial as data-sharing and collaborations rise. By investing in these innovative domains, companies can leverage new pathways for growth, maintain competitive advantages, and meet the intricate needs of modern drug development pipelines. Despite the positive trajectory, firms must navigate challenges like intellectual property concerns and evolving regulatory landscapes with strategic foresight and agility, ensuring sustainable growth and advantageous positioning within an inherently dynamic market.

Understanding Market Dynamics in the Contract Research Organization Services Market

The Contract Research Organization Services Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing investments in pharmaceutical research and development
    • Growing penetration of biologics and nuclear medicines
    • Rise in adoption of outsourced services for research activities
  • Market Restraints
    • Concerns associated with data management and integrity
  • Market Opportunities
    • Adoption of digitized and agile manufacturing and research development techniques by CROs
    • Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
  • Market Challenges
    • Issues of patient recruitment and retention for clinical research

Exploring Porter’s Five Forces for the Contract Research Organization Services Market

Porter’s Five Forces framework further strengthens the insights of the Contract Research Organization Services Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Contract Research Organization Services Market

External macro-environmental factors deeply influence the performance of the Contract Research Organization Services Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Contract Research Organization Services Market

The Contract Research Organization Services Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Contract Research Organization Services Market

The Contract Research Organization Services Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Contract Research Organization Services Market

The Contract Research Organization Services Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contract Research Organization Services Market, highlighting leading vendors and their innovative profiles. These include AccuLab Life Sciences, ACTIVA-CRO, Advanced Clinical Research Services, LLC, BioAgile Therapeutics Pvt. Ltd., Caidya, Calian Group Ltd., Celerion, Inc., Charles River Laboratories International, Inc., Clinical Trial Service B.V. by PCM Trials, Cromsource by ClinChoice, CTI Clinical Trial & Consulting, Distefar del Sur SL, Ergomed PLC, Firma Clinical Research, LLC, Frontage Holdings Corporation, Geistek Pharma S.L., HCL Technologies Limited, Icon PLC, INQUIS, IQVIA Holdings Inc., KCR S.A., Laboratory Corporation of America Holdings, León Research, S.L., Linical Co., Ltd., Medpace Holdings, Inc., Novotech Health Holdings, OPIS S.r.l., Oxon Epidemiology, S.L., Parexel International Corporation, Pepgra, Pharmaron Beijing Co., Ltd., Pivotal, S.L.U., PPD Inc. by Thermo Fisher Scientific Inc., Prometrika, LLC, ProRelix Services LLP, PSI CRO AG, QualitecFarma S.L., SGS S.A., Syncro Clinical Research SRL, Syneos Health, Inc., The Emmes Company, LLC, Veeda Clinical Research Limited, Vial Health Technology, Inc., Worldwide Clinical Trials Holdings Inc., WuXi AppTec Co., Ltd., and X7 Research.

Market Segmentation & Coverage

This research report categorizes the Contract Research Organization Services Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Clinical Research Services
    • Consulting Services
    • Data Management Services
    • Early Phase Development Services
      • Chemistry, Manufacturing & Control
      • Discovery Studies
      • Preclinical Services
        • Pharmacokinetics/Pharmacodynamics
        • Toxicology Testing
    • Laboratory Services
      • Analytical Testing
        • Batch Release Testing
        • Physical Characterization
        • Raw Material Testing
        • Stability Testing
      • Bioanalytical Testing
  • Trial Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Therapeutic Area
    • Cardiovascular Disease
    • Dermatology
    • Gastrointestinal
    • Genitourinary & Women’s Health
    • Hematology
    • Immunological Disorders
    • Infectious Diseases
    • Metabolic Disorders/Endocrinology
    • Neurology
    • Oncology
    • Ophthalmology
    • Psychiatry
    • Respiratory Disorders
  • Molecule Type
    • Cell & Gene Therapy Diseases
    • Vaccines
  • End-User
    • Academic Institutes
    • Medical Device Companies
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing investments in pharmaceutical research and development
5.1.1.2. Growing penetration of biologics and nuclear medicines
5.1.1.3. Rise in adoption of outsourced services for research activities
5.1.2. Restraints
5.1.2.1. Concerns associated with data management and integrity
5.1.3. Opportunities
5.1.3.1. Adoption of digitized and agile manufacturing and research development techniques by CROs
5.1.3.2. Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
5.1.4. Challenges
5.1.4.1. Issues of patient recruitment and retention for clinical research
5.2. Market Segmentation Analysis
5.2.1. Type: Adoption of clinical research services to manage the complexity and duration of clinical trials
5.2.2. Trial Phase: Need for CROs with strong capabilities in real-world data and post-market support
5.2.3. Therapeutic Area: Consistent preference for CRO services in oncology drug development activities
5.2.4. End-User: Need for strong foundational research capabilities by academic and research institutions
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Contract Research Organization Services Market, by Type
6.1. Introduction
6.2. Clinical Research Services
6.3. Consulting Services
6.4. Data Management Services
6.5. Early Phase Development Services
6.5.1. Chemistry, Manufacturing & Control
6.5.2. Discovery Studies
6.5.3. Preclinical Services
6.5.3.1. Pharmacokinetics/Pharmacodynamics
6.5.3.2. Toxicology Testing
6.6. Laboratory Services
6.6.1. Analytical Testing
6.6.1.1. Batch Release Testing
6.6.1.2. Physical Characterization
6.6.1.3. Raw Material Testing
6.6.1.4. Stability Testing
6.6.2. Bioanalytical Testing
7. Contract Research Organization Services Market, by Trial Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
8. Contract Research Organization Services Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular Disease
8.3. Dermatology
8.4. Gastrointestinal
8.5. Genitourinary & Women’s Health
8.6. Hematology
8.7. Immunological Disorders
8.8. Infectious Diseases
8.9. Metabolic Disorders/Endocrinology
8.10. Neurology
8.11. Oncology
8.12. Ophthalmology
8.13. Psychiatry
8.14. Respiratory Disorders
9. Contract Research Organization Services Market, by Molecule Type
9.1. Introduction
9.2. Cell & Gene Therapy Diseases
9.3. Vaccines
10. Contract Research Organization Services Market, by End-User
10.1. Introduction
10.2. Academic Institutes
10.3. Medical Device Companies
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Contract Research Organization Services Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Contract Research Organization Services Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Contract Research Organization Services Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Lindus Health revolutionizes dermatology trials with 'all-in-one dermatology CRO' launch
14.3.2. Allucent secures 5-Year BARDA partnership to advance decentralized clinical trials for medical countermeasures
14.3.3. Strategic merger between palleos healthcare GmbH and OCT Clinical GmbH expands clinical research in Europe
14.3.4. Veeda Clinical Research Bolsters Global Presence with Strategic Acquisition of European CRO, Heads
14.3.5. Innovative Partnership between EUROAPI and SpiroChem Revolutionizes CRO-CDMO Integration for Drug Development
14.3.6. Maridose Launches Innovative CRO Group for Cannabis-Based Drug Development
14.3.7. Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners
14.3.8. Everest Clinical Research Announces the Acquisition of August Research
14.3.9. PRC Clinical and TrialHub Unite to Elevate Clinical Trial Efficiency and Patient Recruitment
14.3.10. OrganaBio Launches Innovative Cell Processing and Cryopreservation Services to Support Decentralized Clinical Trials
14.3.11. MedRhythms Choses Curavit as its Contract Research Organization (CRO) for a Chronic Stroke Decentralized Clinical Trial
14.3.12. Innovating Healthcare through a Strategic Partnership between Worldwide Clinical Trials and Every Cure
14.3.13. ClinChoice Expands Global Reach with Strategic Acquisition of CROMSOURCE
14.3.14. Avania Acquires MAXIS: Enhancing Medtech Development and Commercialization
14.3.15. TFS HealthScience Broadens Its Horizons with Appletree CI Group Acquisition
14.4. Strategy Analysis & Recommendation
14.4.1. Veeda Clinical Research Limited
List of Figures
FIGURE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET RESEARCH PROCESS
FIGURE 2. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET DYNAMICS
TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BATCH RELEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHYSICAL CHARACTERIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RAW MATERIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CELL & GENE THERAPY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 84. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 85. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 86. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 87. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 88. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 96. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 98. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 131. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 132. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 133. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 134. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 135. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 136. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 137. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 140. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 141. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 142. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 143. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 144. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 145. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 146. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 160. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 161. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 162. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 163. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 164. JAPAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 212. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 213. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 215. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 216. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 217. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 218. THAILAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 221. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 222. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 238. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 240. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 241. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 242. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 243. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 244. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 245. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 246. DENMARK CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 249. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 250. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 251. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 252. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 253. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 254. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 258. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 259. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 260. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 261. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 262. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 263. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 264. FINLAND CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 267. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 268. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 270. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 271. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 272. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 273. FRANCE CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2030 (USD MILLION)
TABLE 276. GERMANY CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2030 (USD MILLI

Companies Mentioned

The leading players in the Contract Research Organization Services market, which are profiled in this report, include:
  • AccuLab Life Sciences
  • ACTIVA-CRO
  • Advanced Clinical Research Services, LLC
  • BioAgile Therapeutics Pvt. Ltd.
  • Caidya
  • Calian Group Ltd.
  • Celerion, Inc.
  • Charles River Laboratories International, Inc.
  • Clinical Trial Service B.V. by PCM Trials
  • Cromsource by ClinChoice
  • CTI Clinical Trial & Consulting
  • Distefar del Sur SL
  • Ergomed PLC
  • Firma Clinical Research, LLC
  • Frontage Holdings Corporation
  • Geistek Pharma S.L.
  • HCL Technologies Limited
  • Icon PLC
  • INQUIS
  • IQVIA Holdings Inc.
  • KCR S.A.
  • Laboratory Corporation of America Holdings
  • León Research, S.L.
  • Linical Co., Ltd.
  • Medpace Holdings, Inc.
  • Novotech Health Holdings
  • OPIS S.r.l.
  • Oxon Epidemiology, S.L.
  • Parexel International Corporation
  • Pepgra
  • Pharmaron Beijing Co., Ltd.
  • Pivotal, S.L.U.
  • PPD Inc. by Thermo Fisher Scientific Inc.
  • Prometrika, LLC
  • ProRelix Services LLP
  • PSI CRO AG
  • QualitecFarma S.L.
  • SGS S.A.
  • Syncro Clinical Research SRL
  • Syneos Health, Inc.
  • The Emmes Company, LLC
  • Veeda Clinical Research Limited
  • Vial Health Technology, Inc.
  • Worldwide Clinical Trials Holdings Inc.
  • WuXi AppTec Co., Ltd.
  • X7 Research

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 96.31 Billion
Forecasted Market Value ( USD ) by 2030 $ 180.36 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned46

Related Topics

Related Reports

Contract Research & Manufacturing Services Market by Service Type, Therapeutic Area, End User, Phases, Application, Product Type, Technology - Global Forecast 2025-2030 - Product Image

Contract Research & Manufacturing Services Market by Service Type, Therapeutic Area, End User, Phases, Application, Product Type, Technology - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Healthcare Contract Research Organization Market by Type, Service - Global Forecast 2025-2030 - Product Image

Healthcare Contract Research Organization Market by Type, Service - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Medical Device Contract Research Organization Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), Service, Device Type, Region, and Segment Forecasts, 2024-2030 - Product Image

Medical Device Contract Research Organization Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), Service, Device Type, Region, and Segment Forecasts, 2024-2030

  • Report
  • 183 Pages
  • Global
From
Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029 - Product Image

Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029

  • Report
  • 483 Pages
  • Global
From
In Vivo Contract Research Organization (CRO) - Global Strategic Business Report - Product Image

In Vivo Contract Research Organization (CRO) - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.